Anti-MED13 antibodies are used in the immunodetection of the protein mediator complex subunit 13. In humans, the canonical protein has a reported length of 2174 amino acid residues and a mass of 239.3 kDa. Its subcellular localization is in the nucleus. It is ubiquitously expressed across many tissue types. A member of the Mediator complex subunit 13 protein family, MED13 is a known component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. The MED13 gene has been associated with the disease, Intellectual developmental disorder. Synonyms for this target antigen include DRIP250, HSPC221, MRD61, THRAP1, TRAP240, and ARC250. MED13 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of MED13 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.